PREDISURGE

The company’s main activity is to develop predictive software solutions for cardiovascular interventions using ML/AI. The company has patented its innovative technology of patient-specific numerical simulation, dedicated to cardiovascular interventions (in particular mini-invasive interventions such as: (i) endovascular aortic repair (EVAR), including the Fenestrated one (FEVAR) and (ii) transcatheter mitral valve repair (TMVr)).